ATACAND HCT - Candesartan cilexetil and Hydrochlorothiazide
Navigation: NDC > Supplier starting with: A > ASTRAZENECA LP| Field | Value |
|---|---|
| NDC Code: | 0186-0322 |
| Proprietary Name: | ATACAND HCT |
| Suffix: | |
| Non-Proprietary Name: | Candesartan cilexetil and Hydrochlorothiazide |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 28-09-2000 |
| Category Name: | NDA |
| Application Number: | NDA021093 |
| Labeler: | ASTRAZENECA LP |
| Substance Name: | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 32; 12.5 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |